Market Closed -
Other stock markets
|
Pre-market 08:18:48 am | |||
26.32 USD | +0.23% | 26.34 | +0.09% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 23 | Pfizer vs Moderna battle over COVID vaccine patents begins in UK | RE |
Financials (USD)
Sales 2024 * | 59.96B | Sales 2025 * | 62.57B | Capitalization | 149B |
---|---|---|---|---|---|
Net income 2024 * | 6.75B | Net income 2025 * | 9.29B | EV / Sales 2024 * | 3.27 x |
Net Debt 2024 * | 47.04B | Net Debt 2025 * | 41.91B | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
14
x | Employees | 88,000 |
Yield 2024 * |
6.44% | Yield 2025 * |
6.61% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | +0.28% | ||
1 week | +2.45% | ||
Current month | -5.15% | ||
1 month | -3.80% | ||
3 months | -7.42% | ||
6 months | -14.66% | ||
Current year | -8.58% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 215 M€ | +11.92% | - | |
9.37% | 18 M€ | +4.24% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 26.32 | +0.23% | 24,297,821 |
24-04-22 | 26.26 | +1.00% | 35,678,657 |
24-04-19 | 26 | +2.40% | 38,372,801 |
24-04-18 | 25.39 | -0.12% | 35,788,351 |
24-04-17 | 25.42 | -1.05% | 43,828,892 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.58% | 149B | |
+27.92% | 672B | |
+27.06% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.36% | 217B | |
+6.19% | 199B | |
-8.96% | 204B | |
-4.99% | 147B |
- Stock Market
- Equities
- PFE Stock